CoverageForm 410-K10-Q8-K13D13G13F

ESPR Esperion Therapeutics, Inc. - 8-K

Filed Mar 10, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001628280-26-016230
No items extracted yet - this filing's body hasn't been ingested (or the item parser couldn't find structured headings).